HomeHOWL • NASDAQ
add
Werewolf Therapeutics Inc
Previous close
$2.24
Day range
$2.13 - $2.25
Year range
$1.57 - $8.19
Market cap
94.40M USD
Avg Volume
174.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 1.14M | -85.86% |
Operating expense | 4.83M | 5.85% |
Net income | -17.25M | -238.35% |
Net profit margin | -1.51K | -2,291.98% |
Earnings per share | -0.38 | -174.00% |
EBITDA | -18.51M | -228.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 135.30M | -1.56% |
Total assets | 153.70M | -17.02% |
Total liabilities | 49.68M | -25.44% |
Total equity | 104.02M | — |
Shares outstanding | 43.70M | — |
Price to book | 0.94 | — |
Return on assets | -28.61% | — |
Return on capital | -30.62% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -17.25M | -238.35% |
Cash from operations | -14.18M | -29.81% |
Cash from investing | -17.00K | 90.66% |
Cash from financing | -9.72M | -1,504.62% |
Net change in cash | -23.91M | -129.70% |
Free cash flow | -8.06M | 19.42% |
About
Founded
2017
Headquarters
Website
Employees
45